Utah Depreciation vs End Period Cash Flow Analysis

UTMD Stock  USD 63.62  0.22  0.34%   
Utah Medical financial indicator trend analysis is much more than just breaking down Utah Medical Products prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Utah Medical Products is a good investment. Please check the relationship between Utah Medical Depreciation and its End Period Cash Flow accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Utah Medical Products. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Depreciation vs End Period Cash Flow

Depreciation vs End Period Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Utah Medical Products Depreciation account and End Period Cash Flow. At this time, the significance of the direction appears to have strong relationship.
The correlation between Utah Medical's Depreciation and End Period Cash Flow is 0.79. Overlapping area represents the amount of variation of Depreciation that can explain the historical movement of End Period Cash Flow in the same time period over historical financial statements of Utah Medical Products, assuming nothing else is changed. The correlation between historical values of Utah Medical's Depreciation and End Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Depreciation of Utah Medical Products are associated (or correlated) with its End Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when End Period Cash Flow has no effect on the direction of Depreciation i.e., Utah Medical's Depreciation and End Period Cash Flow go up and down completely randomly.

Correlation Coefficient

0.79
Relationship DirectionPositive 
Relationship StrengthSignificant

Depreciation

Depreciation indicates how much of Utah Medical Products value has been used up. For tax purposes Utah Medical can deduct the cost of the tangible assets it purchases as business expenses. However, Utah Medical Products must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.

End Period Cash Flow

Most indicators from Utah Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Utah Medical Products current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Utah Medical Products. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
The current year's Enterprise Value is expected to grow to about 202 M, whereas Selling General Administrative is forecasted to decline to about 6.9 M.
 2021 2022 2023 2024 (projected)
Gross Profit30.9M32.2M30.0M20.6M
Total Revenue49.1M52.3M50.2M36.6M

Utah Medical fundamental ratios Correlations

-0.310.530.050.970.83-0.830.960.880.190.020.880.6-0.66-0.230.950.02-0.81-0.120.790.9-0.24-0.18-0.35-0.83-0.83
-0.31-0.30.79-0.52-0.220.7-0.53-0.560.52-0.07-0.560.18-0.120.95-0.290.520.150.95-0.34-0.540.690.070.93-0.06-0.06
0.53-0.3-0.180.530.63-0.610.580.61-0.190.080.610.12-0.24-0.150.53-0.51-0.69-0.160.480.61-0.48-0.58-0.51-0.3-0.3
0.050.79-0.18-0.170.110.4-0.2-0.290.67-0.04-0.290.5-0.480.790.010.68-0.060.89-0.14-0.250.710.360.86-0.44-0.43
0.97-0.520.53-0.170.77-0.931.00.940.00.030.940.48-0.52-0.450.94-0.13-0.75-0.360.810.95-0.41-0.2-0.55-0.71-0.71
0.83-0.220.630.110.77-0.580.790.590.450.010.590.56-0.82-0.020.670.07-0.930.020.470.620.0-0.29-0.29-0.83-0.83
-0.830.7-0.610.4-0.93-0.58-0.93-0.980.36-0.01-0.98-0.190.230.67-0.860.390.580.59-0.85-0.980.710.310.730.440.44
0.96-0.530.58-0.21.00.79-0.930.940.00.050.940.46-0.53-0.460.93-0.14-0.79-0.370.80.95-0.42-0.24-0.58-0.71-0.71
0.88-0.560.61-0.290.940.59-0.980.94-0.3-0.011.00.26-0.26-0.550.92-0.33-0.61-0.460.891.0-0.66-0.33-0.62-0.51-0.51
0.190.52-0.190.670.00.450.360.0-0.30.04-0.30.64-0.780.66-0.010.69-0.370.68-0.28-0.260.860.290.54-0.61-0.61
0.02-0.070.08-0.040.030.01-0.010.05-0.010.04-0.010.08-0.02-0.050.03-0.01-0.11-0.05-0.080.00.08-0.02-0.080.010.01
0.88-0.560.61-0.290.940.59-0.980.941.0-0.3-0.010.26-0.26-0.550.92-0.33-0.61-0.460.891.0-0.66-0.33-0.62-0.51-0.51
0.60.180.120.50.480.56-0.190.460.260.640.080.26-0.740.280.490.46-0.530.370.370.310.380.260.19-0.71-0.71
-0.66-0.12-0.24-0.48-0.52-0.820.23-0.53-0.26-0.78-0.02-0.26-0.74-0.3-0.47-0.580.75-0.36-0.23-0.3-0.48-0.14-0.110.920.92
-0.230.95-0.150.79-0.45-0.020.67-0.46-0.550.66-0.05-0.550.28-0.3-0.270.51-0.010.98-0.38-0.520.750.040.85-0.19-0.18
0.95-0.290.530.010.940.67-0.860.930.92-0.010.030.920.49-0.47-0.27-0.07-0.7-0.160.870.94-0.4-0.23-0.35-0.71-0.71
0.020.52-0.510.68-0.130.070.39-0.14-0.330.69-0.01-0.330.46-0.580.51-0.07-0.050.58-0.18-0.290.80.510.62-0.49-0.49
-0.810.15-0.69-0.06-0.75-0.930.58-0.79-0.61-0.37-0.11-0.61-0.530.75-0.01-0.7-0.05-0.04-0.47-0.630.030.410.310.80.8
-0.120.95-0.160.89-0.360.020.59-0.37-0.460.68-0.05-0.460.37-0.360.98-0.160.58-0.04-0.29-0.430.750.140.88-0.29-0.29
0.79-0.340.48-0.140.810.47-0.850.80.89-0.28-0.080.890.37-0.23-0.380.87-0.18-0.47-0.290.9-0.59-0.3-0.4-0.45-0.46
0.9-0.540.61-0.250.950.62-0.980.951.0-0.260.01.00.31-0.3-0.520.94-0.29-0.63-0.430.9-0.62-0.31-0.59-0.55-0.55
-0.240.69-0.480.71-0.410.00.71-0.42-0.660.860.08-0.660.38-0.480.75-0.40.80.030.75-0.59-0.620.470.75-0.28-0.28
-0.180.07-0.580.36-0.2-0.290.31-0.24-0.330.29-0.02-0.330.26-0.140.04-0.230.510.410.14-0.3-0.310.470.32-0.07-0.07
-0.350.93-0.510.86-0.55-0.290.73-0.58-0.620.54-0.08-0.620.19-0.110.85-0.350.620.310.88-0.4-0.590.750.32-0.03-0.03
-0.83-0.06-0.3-0.44-0.71-0.830.44-0.71-0.51-0.610.01-0.51-0.710.92-0.19-0.71-0.490.8-0.29-0.45-0.55-0.28-0.07-0.031.0
-0.83-0.06-0.3-0.43-0.71-0.830.44-0.71-0.51-0.610.01-0.51-0.710.92-0.18-0.71-0.490.8-0.29-0.46-0.55-0.28-0.07-0.031.0
Click cells to compare fundamentals

Utah Medical Account Relationship Matchups

Utah Medical fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets109.8M111.7M115.6M123.9M135.5M142.2M
Other Current Liab2.4M2.9M2.7M4.3M3.6M2.6M
Total Current Liabilities3.4M3.8M3.6M5.8M4.7M4.6M
Total Stockholder Equity101.1M102.8M107.1M114.3M128.3M134.7M
Property Plant And Equipment Net10.7M11.3M11.0M10.6M10.6M9.6M
Net Debt(42.4M)(51.3M)(60.6M)(74.7M)(92.6M)(87.9M)
Retained Earnings110.8M111.0M115.3M126.0M138.3M145.3M
Cash42.8M51.6M61.0M75.1M92.9M97.5M
Non Current Assets Total54.9M49.5M42.4M34.0M29.2M27.1M
Non Currrent Assets Other54.9M(49.5M)(2.1M)(1.5M)(1.0)(0.95)
Cash And Short Term Investments42.8M51.6M61.0M75.1M92.9M97.5M
Net Receivables4.7M4.1M5.1M5.5M3.3M4.5M
Common Stock Shares Outstanding3.7M3.7M3.7M3.6M3.6M5.0M
Liabilities And Stockholders Equity109.8M111.7M115.6M123.9M135.5M142.2M
Non Current Liabilities Total5.2M5.1M4.8M3.9M2.4M2.3M
Inventory6.9M6.2M6.6M8.8M9.6M10.1M
Other Current Assets443K346K456K515K481K457.0K
Other Stockholder Equity17K115K841K251K594.0K564.3K
Total Liab8.7M8.9M8.4M9.6M7.1M9.7M
Property Plant And Equipment Gross10.7M11.3M33.9M33.2M34.3M36.0M
Total Current Assets54.9M62.3M73.2M89.9M106.3M111.6M
Accumulated Other Comprehensive Income(9.8M)(8.3M)(9.1M)(12.0M)(10.7M)(10.1M)
Intangible Assets30.2M24.0M17.3M10.4M4.9M4.7M
Accounts Payable1.1M788K761K1.2M769K1.3M
Property Plant Equipment10.7M11.3M11.0M10.2M11.8M10.1M
Good Will14.0M14.2M14.1M13.4M13.7M13.0M
Other Liab4.9M4.8M4.5M3.3M3.8M4.9M
Net Tangible Assets56.9M64.7M75.7M90.5M104.1M62.4M
Retained Earnings Total Equity110.8M111.0M115.3M126.0M144.9M93.3M
Capital Surpluse18K115K841K251K225.9K214.6K
Deferred Long Term Liab521K651K577K549K494.1K356.6K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Utah Medical Products is a strong investment it is important to analyze Utah Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Utah Medical's future performance. For an informed investment choice regarding Utah Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Utah Medical Products. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Utah Medical. If investors know Utah will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Utah Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.05)
Dividend Share
1.2
Earnings Share
4.28
Revenue Per Share
12.392
Quarterly Revenue Growth
(0.20)
The market value of Utah Medical Products is measured differently than its book value, which is the value of Utah that is recorded on the company's balance sheet. Investors also form their own opinion of Utah Medical's value that differs from its market value or its book value, called intrinsic value, which is Utah Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Utah Medical's market value can be influenced by many factors that don't directly affect Utah Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Utah Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Utah Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Utah Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.